NASDAQ:RNLX - Nasdaq - US75973T1016 - ADR - Currency: USD
Taking everything into account, RNLX scores 2 out of 10 in our fundamental rating. RNLX was compared to 35 industry peers in the Health Care Technology industry. Both the profitability and financial health of RNLX have multiple concerns. While showing a medium growth rate, RNLX is valued expensive at the moment.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -109.75% | ||
ROE | -250.48% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 20.6% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.41 | ||
Debt/FCF | N/A | ||
Altman-Z | -5.75 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.76 | ||
Quick Ratio | 1.71 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
0.2071
+0.01 (+5.66%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 5.05 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 0.93 | ||
P/tB | 2.89 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -109.75% | ||
ROE | -250.48% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 20.6% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.41 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 0% | ||
Cap/Sales | 0% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 1.76 | ||
Quick Ratio | 1.71 | ||
Altman-Z | -5.75 |